Niacin results in reduced monocyte adhesion in patients with type 2 diabetes mellitus

Atherosclerosis

Volumn 215, Issue 1, 2011, Pages 176-179

  Tavintharan, S ^a   Woon, K ^a   Pek, L T ^a   Jauhar, N ^a   Dong, X ^a   Lim, S C ^a   Sum, C F ^a  

^a KHOO TECK PUAT HOSPITAL   (Singapore)

Author keywords

Cell adhesion molecules; Cholesterol; Diabetes; Lipid modifying; Monocytes; Niacin

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CD31 ANTIGEN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; CELL ASSAY; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; DRUG RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADIPONECTIN; ANTIGENS, CD31; CARDIOVASCULAR DISEASES; CELL ADHESION; CELL ADHESION MOLECULES; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; FEMALE; HUMANS; LIPID METABOLISM; MALE; MONOCYTES; NIACIN;

EID: 79952103415     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.12.020     Document Type: Article

References (15)

1. Oishi Y., Wakatsuki T., Nishikado A., et al. Circulating adhesion molecules and severity of coronary atherosclerosis. Coron Artery Dis 2000, 11(1):77-81.
2. Canner P.L., Berge K.G., Wenger N.K., et al. Fifteen year mortality in coronary drug project patients: long-term benefit with niacin. J Am Coll Cardiol 1986, 8(6):1245-1255.
3. Taylor A.J., Villines T.C., Stanek E.J., et al. Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med 2009, 361(22):2113-2122.
4. Garg R., Malinow M., Pettinger M., et al. Niacin treatment increases plasma homocyst(e)ine levels. Am Heart J 1999, 138(6 Pt 1):1082-1087.
5. Tavintharan S., Sivakumar M., Lim S.C., et al. Niacin affects cell adhesion molecules and plasminogen activator inhibitor-1 in HepG2 cells. Clin Chim Acta 2007, 376(1-2):41-44.
6. Guyton J.R., Blazing M.A., Hagar J., et al. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group. Arch Intern Med 2000, 160(8):1177-1184.
7. Thoenes M., Oguchi A., Nagamia S., et al. The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome. Int J Clin Pract 2007, 61(11):1942-1948.
8. Westphal S., Borucki K., Taneva E., et al. Adipokines and treatment with niacin. Metabolism 2006, 55(10):1283-1285.
9. Tavintharan S., Lim S.C., Sum C.F. Effects of niacin on cell adhesion and early atherogenesis: biochemical and functional findings in endothelial cells. Basic Clin Pharmacol Toxicol 2009, 104(3):206-210.
10. Kubli S., Waeber B., Dalle-Ave A., et al. Reproducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function. J Cardiovasc Pharmacol 2000, 36(5):640-648.
11. Ganji S.H., Qin S., Zhang L., et al. Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells. Atherosclerosis 2009, 202(1):68-75.
12. Cockerill G.W., Rye K.A., Gamble J.R., et al. High density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995, 15:1987-1994.
13. Staunton D.E., Dustin M.L., Erickson H.P. The arrangement of the immunoglobulin-like domains of ICAM-l and the binding sites for LFA-I and rhinovirus. Cell 1990, 61:243-254.
14. Rezaie-Majd A., Prager G.W., Bucek R.A., et al. Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2003, 23(3):397-403.
15. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001, 285:1711-1718.